These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32529542)

  • 1. Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.
    Gorantla NV; Chinnathambi S
    Cell Mol Neurobiol; 2021 Aug; 41(6):1175-1181. PubMed ID: 32529542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
    Gorantla NV; Chinnathambi S
    J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation or aggregation: the ramifications of post-translational modifications on tau.
    Park S; Lee JH; Jeon JH; Lee MJ
    BMB Rep; 2018 Jun; 51(6):265-273. PubMed ID: 29661268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau).
    Xu Y; Zhang S; Zheng H
    Autophagy; 2019 Apr; 15(4):583-598. PubMed ID: 30290707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau phosphorylation affects its axonal transport and degradation.
    Rodríguez-Martín T; Cuchillo-Ibáñez I; Noble W; Nyenya F; Anderton BH; Hanger DP
    Neurobiol Aging; 2013 Sep; 34(9):2146-57. PubMed ID: 23601672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase ROCK inhibitors reduce oligomeric tau protein.
    Hamano T; Shirafuji N; Yen SH; Yoshida H; Kanaan NM; Hayashi K; Ikawa M; Yamamura O; Fujita Y; Kuriyama M; Nakamoto Y
    Neurobiol Aging; 2020 May; 89():41-54. PubMed ID: 31982202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunolocalization of Tom1 in relation to protein degradation systems in Alzheimer's disease.
    Makioka K; Yamazaki T; Takatama M; Ikeda M; Murayama S; Okamoto K; Ikeda Y
    J Neurol Sci; 2016 Jun; 365():101-7. PubMed ID: 27206884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of transmembrane domain of lysosome-associated membrane protein type 2a (LAMP-2A) reveals key features for substrate specificity in chaperone-mediated autophagy.
    Rout AK; Strub MP; Piszczek G; Tjandra N
    J Biol Chem; 2014 Dec; 289(51):35111-23. PubMed ID: 25342746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chaperone-mediated autophagy in degrading Huntington's disease-associated huntingtin protein.
    Qi L; Zhang XD
    Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):83-91. PubMed ID: 24323530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
    Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
    Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperone-mediated autophagy.
    Dice JF
    Autophagy; 2007; 3(4):295-9. PubMed ID: 17404494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Implications of Autophagy in Alzheimer's Disease.
    Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
    Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition metal nickel prevents Tau aggregation in Alzheimer's disease.
    Gorantla NV; Das R; Balaraman E; Chinnathambi S
    Int J Biol Macromol; 2020 Aug; 156():1359-1365. PubMed ID: 31770557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chaperone-mediated autophagy in huntingtin degradation.
    Qi L; Zhang XD; Wu JC; Lin F; Wang J; DiFiglia M; Qin ZH
    PLoS One; 2012; 7(10):e46834. PubMed ID: 23071649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of tau protein by autophagy and proteasomal pathways.
    Wang Y; Mandelkow E
    Biochem Soc Trans; 2012 Aug; 40(4):644-52. PubMed ID: 22817709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.